Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma

Authors:
  • JKJ.E. Krook
    J.E. Krook
  • JHJ.F. Hilton
    J.F. Hilton
  • GMG.D. Malkasian
    G.D. Malkasian
  • LEL.K. Everson
    L.K. Everson
  • JJJ.A. Jefferies
    J.A. Jefferies
  • JMJ.A. Mailliard
    J.A. Mailliard

Abstract
No abstract available